|本期目录/Table of Contents|

[1]李岩,牛秀珑,郁春艳,等.IL-17A可以促进卵巢癌的腹腔转移[J].天津医科大学学报,2020,26(06):518-520,525.
　LI Yan,NIU Xiu-long,YU Chun-yan,et al.IL-17A promotes intraperitoneal metastasis of ovarian cancer[J].Journal of Tianjin Medical University,2020,26(06):518-520,525.
点击复制

IL-17A可以促进卵巢癌的腹腔转移(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
26卷
期数:
2020年06期
页码:
518-520,525
栏目:
基础医学
出版日期:
2020-11-20

文章信息/Info

Title:
IL-17A promotes intraperitoneal metastasis of ovarian cancer
作者:
李岩1; 牛秀珑2; 郁春艳1; 陈燕1; 沈洋洋1; 邓为民1
1.天津医科大学基础医学院免疫学系，国家教育部免疫微环境与疾病重点实验室，天津 300070；2.中国人民武装警 察部队特色医学中心勤务环境皮肤疾病防治研究所，天津 300162
Author(s):
LI Yan1;  NIU Xiu-long2;  YU Chun-yan1;  CHEN Yan1;  SHEN Yang-yang1;  DENG Wei-min 1
1.Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Key Laboratory of Diseases and Microenvironment of Ministry of Education of China, Tianjin 300070, China; 2.Department of Prevention, Therapy of Skin Disease in the Security Environment, Characteristic Medical Center of Chinese People′s Armed Police Force, Tianjin 300162, China
关键词:
IL-17A; 卵巢癌; 转移; 侵袭
Keywords:
IL-17A;  ovarian cancer;  metastasis;  invasion
分类号:
R737.31
DOI:
-
文献标志码:
A
摘要:
目的：探讨白细胞介素（IL）-17A对卵巢癌（OvCa）腹腔转移的影响。方法：以C57BL/6为遗传背景的野生型 （WT）小鼠和IL-17A 缺陷（IL-17A-/-）小鼠为研究对象，腹腔注射同基因小鼠OvCa细胞系ID8，检测内源性IL-17A对 OvCa腹腔种植瘤生长的影响。应用MTT法检测不同浓度的重组小鼠IL-17A（rmIL-17A）对ID8细胞增殖的影响；应用划 痕实验检测不同浓度的rmIL-17A对ID8细胞迁移能力的影响；应用Transwell侵袭实验检测不同浓度的rmIL-17A对ID8细 胞侵袭能力的影响。结果：与IL-17A-/-小鼠相比，WT小鼠腹腔内肠系膜、腹膜后淋巴结、脾脏和肾脏表面等处均见密 集瘤结节转移灶，且腹腔内瘤结节数量显著增多（均P＜0.01）。体外实验结果显示，与对照组相比，不同浓度的 rmIL-17A对ID8细胞增殖无影响（均P>0.05）；与对照组相比，10 ng/mL的rmIL-17A作用6 h后可促进ID8细胞迁移，1 ng/mL和10 ng/mL的rmIL-17A作用12 h后可显著促进ID8细胞迁移（均P＜0.05）；与对照组相比，干预24 h后，1 ng/mL和10 ng/mL的rmIL-17A对ID8细胞的侵袭能力均有促进作用（均P＜0.05）。结论：IL-17A可以促进卵巢癌的腹腔 转移。
Abstract:
Objective: To investigate the effect of interleukin-17A（IL-17A） on intraperitoneal metastasis of ovarian cancer（OvCa）. Methods: Wild-type (WT) mice and IL-17A-deficient (IL-17A-/-) mice with C57BL/6 genetic background were used as research subjects. The effect of endogenous IL-17A on OvCa intraperitoneal metastasis was evaluated by intraperitoneal injection of syngeneic mouse ovarian cancer cell line ID8. MTT assay was used to detect the effect of recombinant mouse IL-17A(rmIL-17A) on ID8 cells proliferation. Wound healing assay was used to detect the effect of rmIL-17A on ID8 cells migration. Transwell invasion assay was used to detect the effect of rmIL-17A on the invasion ability of ID8 cells. Results: Compared with IL-17A-/- mice, much denser tumor nodules were observed on the surface of mesentery, retroperitoneal lymph nodes, spleen and kidney in WT mice, and the number of nodules in the abdominal cavity was significantly increased (all P<0.01). In vitro results showed that rmIL-17A had no effect on ID8 cells proliferation. Compared with control group, rmIL-17A at 10 ng/mL could promote the migration of ID8 cells after 6 h, and rmIL-17A at 1 ng/mL and 10 ng/mL could significantly promote the migration of ID8 cells after 12 h (all P＜0.05). Compared with control group, after 24 hours of intervention, 1 ng/mL and 10 ng/mL rmIL-17A both promoted the invasion of ID8 cells (all P＜0.05). Conclusion: IL-17A can enhance the intraperitoneal metastasis of OvCa.

参考文献/References:

[1] Lin J，Wang Y C，Sun Z J，et al. 3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance（MDR） proteins function[J]. Biomed Pharmacother，2019，116：108992
[2] Yu C Y，Niu X L，Du Y R，et al. IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p- STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment[J]. Cancer Immunol Immunother，2020，69（1）：115
[3] Monteleone I，Pallone F，Monteleone G. Th17-related cytokines： new players in the control of chronic intestinal inflammation[J]. BMC Med，2011，9：122
[4] Xing X, Yang J，Yang X， et al. IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway[J]. PLoS One，2013，8（12）：e85032
[5] Numasaki M, Tsukamoto H， Tomioka Y， et al. A heterodimeric cytokine，consisting of IL-17A and IL-17F，promotes migration and capillary-like tube formation of human vascular endothelial cells[J]. Tohoku J Exp Med，2016，240（1）：47
[6] Li S S， Li C K， Tang M Y， et al. Modeling ovarian cancer multicellular spheroid behavior in a dynamic 3D peritoneal microdevice[J]. J Vis Exp，2017，（120）：27
[7] Chen Z J， Zhang Z, Xie B B, et al.Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer[J]. Eur Rev Med Pharmacol Sci，2016，20（16）：3373
[8] Beltran E G，Denisenko T V，Zhivotovsky B，et al. Tudor staphylococcal nuclease： biochemistry and functions[J]. Cell Death Differ，2016，23（11）：1739
[9] Liang H，Yu T，Han Y，et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression[J]. Mol Cancer，2018，17（1）： 119
[10] Azais H，Mordon S, Collinet P. Intraperitoneal photodynamic therapy for peritoneal metastasis of epithelial ovarian cancer. Limits and future prospects[J]. Gynecol Obstet Fertil Senol，2017，45（4）： 249
[11] Ladanyi A，Mukherjee A，Kenny H A，et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis[J]. Oncogene，2018，37（17）：2285
[12] Nakamura K，Sawada K，Kinose Y，et al. Exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells[J]. Mol Cancer Res，2017，15（1）：78
[13] Sugauchi F，Orito E，Kato H，The complete nucleotide sequences of serotype ′O′ and ′A′ Indian vaccine strains of foot-and-mouth disease virus[J]. Arch Virol，2011，156（11）：2117
[14] Jayakumar A，Bothwell ALM. Functional diversity of myeloid-derived suppressor cells：the multitasking hydra of cancer[J]. J Immunol，2019，203（5）：1095
[15] Chen Y，Zhong M，Yuan G，et al. Interleukin-17 induces angiogenesis in vitro via CXCL8 and CCL2 in retinal pigment epithelium[J]. Mol Med Rep，2018，17（3）：4627
[16] Ohman A W，Hasan N，Dinulescu D M. Advances in tumor screening，imaging，and avatar technologies for high-grade serous ovarian cancer[J]. Front Oncol，2014，4：322
[17] Worzfeld T，Pogge E，Huber M，et al. The unique molecular and cellular microenvironment of ovarian cancer[J]. Front Oncol，2017，7：24
[18] Nieman K M，Kenny H A，Penicka C V，et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth[J]. Nat Med，2011，17（11）：1498

相似文献/References:

[1]申彦,张新莹,师宜荃,等.Glut-1、HIF-1α及P53在卵巢癌中的表达及意义[J].天津医科大学学报,2013,19(05):383.
[2]周 闻,杨 臻,刘 民,等.抑癌基因ST7L对卵巢癌细胞增殖、细胞周期和裸鼠移植瘤的影响[J].天津医科大学学报,2016,22(05):373.
　ZHOU Wen,YANG Zhen,LIU Min,et al.Effects of ST7L on cell proliferation, cell cycle in ovarian cancer and tumour xenografts in nude mice[J].Journal of Tianjin Medical University,2016,22(06):373.
[3]范 丹,宋文静,张艳辉,等.PRRX1的表达对卵巢癌血管生成拟态形成及患者预后的影响[J].天津医科大学学报,2018,24(01):1.
　FAN Dan,SONG Wen-jing,ZHANG Yan-hui,et al.Effect of PRRX1 expression on VM formation and prognosis in ovarian cancer[J].Journal of Tianjin Medical University,2018,24(06):1.
[4]王雅蕾,王靖怡 综述,齐丽莎 审校.微环境在卵巢癌发生发展中的作用[J].天津医科大学学报,2020,26(03):288.
[5]李广宁 综述,曹文枫 审校.女性生殖系统双原发癌的研究进展[J].天津医科大学学报,2021,27(06):655.
[6]沈洋洋,牛秀珑,郁春艳,等.外源性IL-6 通过STAT3 通路促进卵巢癌细胞对顺铂 耐药[J].天津医科大学学报,2022,28(03):266.
　SHEN Yang-yang,NIU Xiu-long,YU Chun-yan,et al.Exogenous IL-6 promotes cisplatin resistance of ovarian cancer through STAT3 pathway[J].Journal of Tianjin Medical University,2022,28(06):266.
[7]徐灵灵,牛秀珑,张宏健,等.IL-17A促进卵巢癌顺铂耐药的体外机制探讨[J].天津医科大学学报,2018,24(03):192.
　XU Ling-ling,NIU Xiu-long,ZHANG Hong-jian,et al.Study on the underlying mechanisms of IL-17A promoting the cisplatin-based resistance of ovarian cancer[J].Journal of Tianjin Medical University,2018,24(06):192.
[8]郑小燕,郁春艳,刘俊汝,等.IL-17A对卵巢癌进展的影响及机制研究[J].天津医科大学学报,2023,29(02):148.
　ZHENG Xiao-yan,YU Chun-yan,LIU Jun-ru,et al.Effect and mechanism of IL-17A on the progression of ovarian cancer[J].Journal of Tianjin Medical University,2023,29(06):148.

备注/Memo

备注/Memo:
文章编号 1006-8147（2020）06-0518-03
基金项目 天津市科技计划项目（18YFZCSY00040）；天津市教委重点项目（2016YD01）
作者简介 李岩（1996-），女，硕士在读，研究方向：肿瘤免疫；通信作者：邓为民，E-mail： dengweimin@tmu.edu.cn。
更新日期/Last Update: 2020-11-20